← Back to Search

opioid education for Opioid Use Disorder

N/A
Waitlist Available
Led By Robert M Szabo, MD
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months after surgery
Awards & highlights

Study Summary

This trial will study whether an educational session on pain management can help reduce postoperative opioid use in patients undergoing shoulder surgery.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months after surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months after surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Opioid use
Secondary outcome measures
Number of refills

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: educationExperimental Treatment1 Intervention
The teaching arm would consist of a standardized dialogue the surgeon will complete with the patient in order to familiarize the patient with the risks of over-prescribing opioid medication and set patient expectations regarding the clinic's opioid prescribing pattern protocol, in an effort to minimize the number of opioid pills prescribed or refills required, the amount actually used, and the untoward side effects of opioid use (e.g. respiratory depression, nausea, sedation, restriction from driving, and access to and use by those the medication was not intended).
Group II: no educationActive Control1 Intervention
Standard preoperative care without dedicated teaching regarding opioid use and risks
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
opioid education
2019
N/A
~10

Find a Location

Who is running the clinical trial?

University of California, DavisLead Sponsor
914 Previous Clinical Trials
4,720,705 Total Patients Enrolled
Robert M Szabo, MDPrincipal InvestigatorUniversity of California, Davis
~2 spots leftby May 2025